/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

L

Ludovic Evesque

Centre Antoine Lacassagne(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

110

Papers

2.8K

Citations

24

h-index

39

i10-index

Ludovic Evesque is an academic researcher from Centre Antoine Lacassagne. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Colorectal and Anal Carcinomas & Colorectal Cancer Treatments and Studies. The author has an h-index of 24, co-authored 94 publications.

ORCID: 0000-0001-9537-6454

Research Topics

Gastric Cancer Management and Outcomes Colorectal and Anal Carcinomas Colorectal Cancer Treatments and Studies Pancreatic and Hepatic Oncology Research Cancer Genomics and Diagnostics

Papers by this author

works

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

2022 · ESMO Open · 69 citations

https://doi.org/10.1016/j.esmoop.2022.100529

Sheela Rao Gayathri Anandappa Jaume Capdevila Laëtitia Dahan

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

2024 · Annals of Oncology · 27 citations

https://doi.org/10.1016/j.annonc.2024.06.010

Nicolás A. Fraunhoffer Pascal Hammel Thierry Conroy Rémy Nicolle

Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial

2022 · Digestive and Liver Disease · 23 citations

https://doi.org/10.1016/j.dld.2022.07.008

Clélia Coutzac Frédéric Bibeau Méher Ben Abdelghani Thomas Aparicio

Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence

2020 · Clinical and Translational Radiation Oncology · 20 citations

https://doi.org/10.1016/j.ctro.2020.07.001

Karen Bénézery Lucile Montagné Ludovic Evesque Renaud Schiappa

Faecalibacterium prausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 1707-DURIGAST Trial

2024 · Gastroenterology · 12 citations

https://doi.org/10.1053/j.gastro.2024.10.020

Marius Bredon Karine le Malicot Christophe Louvet Ludovic Evesque

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma

2025 · Communications Medicine · 6 citations

https://doi.org/10.1038/s43856-025-00867-x

David Tougeron C. Louvet Jérôme Desrame Ludovic Evesque

Research topics

topics

Gastric Cancer Management and Outcomes

Colorectal and Anal Carcinomas

Colorectal Cancer Treatments and Studies

Pancreatic and Hepatic Oncology Research

Cancer Genomics and Diagnostics

Chat about Author

Papers

Chat

Click to start Chat